Connect your AI

Citius Oncology, Inc. CTOR Cost Of Revenue

Cost Of Revenue at other companies

XTI Aerospace, Inc.XTIA

$22.55M+15,034%

NXT

Next Technology HoldingNXTT

$387.34K—

HitachiHIT

$4.26M+60.3%

Quantum Computing Inc.QUBT

$4.41M+16,869%

HTF

Heartflow, Inc. Common StockHTFL

$10.42M+12.5%

Wrap TechnologiesWRAP

$420K+147%

Other financials

Income statement

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

Operating cash flow-$3.8M-179%

Valuation

Market cap$60.45M-74.7%

Returns & leverage

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Citius Oncology, Inc.'s cost of revenue?: Citius Oncology, Inc. (CTOR) reported cost of revenue of $328.88K in Q1 2026.